Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 666 | 1,148 | 867 | 7,305 | 4,932 |
| Cost of Goods | 1,008 | 1,847 | 1,101 | 3,701 | 3,090 |
| Gross Profit | -342 | -699 | -234 | 3,604 | 1,842 |
| Operating Expenses | 15,578 | 15,854 | 7,490 | 10,008 | 9,621 |
| Operating Income | -15,912 | -15,706 | -7,623 | -5,703 | -7,689 |
| Interest Expense | -93 | 372 | 535 | 1,437 | 319 |
| Other Income | 12 | -2,497 | -492 | -257 | 3,803 |
| Pre-tax Income | -15,807 | -18,575 | -8,650 | -7,397 | -4,205 |
| Income Tax | N/A | N/A | N/A | -512 | N/A |
| Net Income Continuous | -15,807 | -18,575 | -8,650 | -6,885 | -4,205 |
| Net Income Discontinuous | -6,883 | -22,284 | N/A | 177 | -16,168 |
| Net Income | $-22,690 | $-40,859 | $-8,650 | $-6,708 | $-20,373 |
| EPS Basic Total Ops | -3.87 | -9.03 | -17.40 | -17.40 | -111.95 |
| EPS Basic Continuous Ops | -2.69 | -4.11 | -17.40 | -17.85 | -23.10 |
| EPS Basic Discontinuous Ops | -1.18 | -4.92 | N/A | 0.45 | -88.85 |
| EPS Diluted Total Ops | -3.87 | -9.03 | -17.40 | -17.40 | -111.95 |
| EPS Diluted Continuous Ops | -2.69 | -4.11 | -17.40 | -17.85 | -23.10 |
| EPS Diluted Discontinuous Ops | -1.18 | -4.92 | N/A | 0.45 | -88.85 |
| EPS Diluted Before Non-Recurring Items | N/A | -3.05 | N/A | -10.10 | -100.60 |
| EBITDA(a) | $-15,069 | $-14,652 | $-6,513 | $-1,576 | $-6,662 |